CD8A and neoplasm: Our primary focus will be on CD8+ T cells and the subsets of DCs that that are essential for stimulating a tumor-reactive T cell response, i.e. cross-presenting conventional type 1 dendritic cells (cDC1s) and type I interferon (IFN) producing plasmacytoid DCs (pDCs).